Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-04

Clinical Trial Update: Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer [Phase 2]

View source ↗

Summary

A Phase 2 trial tested whether a proton pump inhibitor can prevent clopidogrel-related peptic ulcers. The study is completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clopidogrel (Plavix) (clopidogrel)
  • Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Peptic Ulcer | Phase 2 | Status: COMPLETED | Results posted: 2013-02-04